Back to results
Completed

Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients

NCT05203458

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Research Site

Shanghai, Shanhai, China

+6 additional locations

View on ClinicalTrials.gov
Prevalence and Clinicopathologic Features of Different HER2 Level in Chinese Breast Cancer Patients — TrialFind